Fluoxetine protects against OVA induced bronchial asthma and depression in rats. (Record no. 28766544)

MARC details
000 -LEADER
fixed length control field 01356 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517233906.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0712
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejphar.2018.08.026
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sherkawy, Marwa M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190213
245 00 - TITLE STATEMENT
Title Fluoxetine protects against OVA induced bronchial asthma and depression in rats.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of pharmacology
Date of publication, distribution, etc. Oct 2018
300 ## - PHYSICAL DESCRIPTION
Extent 25-32 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Asthma
General subdivision physiopathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain-Derived Neurotrophic Factor
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Depression
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dexamethasone
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluoxetine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin E
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-4
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovalbumin
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxidative Stress
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peak Expiratory Flow Rate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rats
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abo-Youssef, Amira M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Salama, Abeer A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ismaiel, Ismaiel E
773 0# - HOST ITEM ENTRY
Title European journal of pharmacology
Related parts vol. 837
-- p. 25-32
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejphar.2018.08.026">https://doi.org/10.1016/j.ejphar.2018.08.026</a>
Public note Available from publisher's website

No items available.